Orchid Pharma's merger with Dhanuka Labs approved by NCLT, targeting combined sales of Rs. 1400-1500 Cr and EBITDA of Rs. 200-250 Cr.

Orchid Pharma LimitedORCHPHARMA · Filed with the exchange

Shareholders receive 161 Orchid shares (FV Rs. 10) for 5 Dhanuka shares (FV Rs. 100). Appointed Date: April 1, 2024.

No comments yet. Be the first.

More from Orchid Pharma Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.